tiprankstipranks
Trending News
More News >
NanoViricides (NNVC)
:NNVC

Compare NanoViricides (NNVC) vs. Competitors

Compare
602 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
NanoViricides
$1.13
$25.45M
-2.32
-1.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
CASI Pharmaceuticals
$1.06
$14.83M
-0.30
-61.72%
1 Buy
0 Hold
0 Sell
Moderate Buy
Enlivex
$0.94
$223.14M
-1.76
-18.26%
1 Buy
1 Hold
0 Sell
Moderate Buy
Akari Therapeutics
$0.28
$9.15M
-76.67%
3 Buy
0 Hold
0 Sell
Strong Buy
Moleculin Biotech
$4.16
$12.81M
-0.07
-90.44%
3 Buy
0 Hold
0 Sell
Strong Buy
SAB Biotherapeutics
$3.98
$189.48M
-1.29
11.80%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NNVC
NanoViricides
1.18
0.06
5.36%
CASI
CASI Pharmaceuticals
0.96
-1.67
-63.61%
ENLV
Enlivex
0.94
-0.25
-21.01%
AKTX
Akari Therapeutics
0.28
-1.01
-78.29%
MBRX
Moleculin Biotech
4.16
-42.84
-91.15%
SABS
SAB Biotherapeutics
3.98
0.31
8.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts